Can combined use of tumor markers in pancreatic cancer be a solution to short- and long-term consequences?: A retrospective study

As in other types of cancer, tumor markers are used in pancreatic ductal adenocarcinoma (PDAC) for disease follow-up, especially after surgery. There has been shown to be a significant correlation between the tumor marker levels and poor prognosis in locally or systemic advanced stage PDAC patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Esen, Ebru, Aslan, Mehmet, Morkavuk, Sevket Baris, Azili, Cem, Ersoz, Siyar, Bahcecioglu, Ibrahim Burak, Unal, Ali Ekrem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019147/
https://www.ncbi.nlm.nih.gov/pubmed/36930073
http://dx.doi.org/10.1097/MD.0000000000033325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019147/
https://www.ncbi.nlm.nih.gov/pubmed/36930073
http://dx.doi.org/10.1097/MD.0000000000033325

Ejemplares similares